161 related articles for article (PubMed ID: 35850052)
1. Effect of Baricitinib on the epithelial-mesenchymal transition of alveolar epithelial cells induced by IL-6.
Liu Y; Hu M; Fan G; Xing N; Zhang R
Int Immunopharmacol; 2022 Sep; 110():109044. PubMed ID: 35850052
[TBL] [Abstract][Full Text] [Related]
2. IL-27 inhibits the TGF-β1-induced epithelial-mesenchymal transition in alveolar epithelial cells.
Dong Z; Tai W; Lei W; Wang Y; Li Z; Zhang T
BMC Cell Biol; 2016 Mar; 17():7. PubMed ID: 26932661
[TBL] [Abstract][Full Text] [Related]
3. Effect of baricitinib in regulating programmed death 1 and ligand programmed cell death ligand 1 through JAK/STAT pathway in psoriasis.
Deepak HB; Prince SE; Deshpande P
Indian J Pharmacol; 2022; 54(3):183-193. PubMed ID: 35848689
[TBL] [Abstract][Full Text] [Related]
4. The JAK inhibitor baricitinib inhibits oncostatin M induction of proinflammatory mediators in ex-vivo synovial derived cells.
Weston S; Macdonald JL; Williams LM; Roussou E; Kang NV; Kiriakidis S; Taylor PC
Clin Exp Rheumatol; 2022 Sep; 40(9):1620-1628. PubMed ID: 34665696
[TBL] [Abstract][Full Text] [Related]
5. microRNA-206 overexpression inhibits epithelial-mesenchymal transition and glomerulosclerosis in rats with chronic kidney disease by inhibiting JAK/STAT signaling pathway.
Zhao SQ; Shen ZC; Gao BF; Han P
J Cell Biochem; 2019 Sep; 120(9):14604-14617. PubMed ID: 31148248
[TBL] [Abstract][Full Text] [Related]
6. Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway.
Dang C; Lu Y; Chen X; Li Q
Front Immunol; 2021; 12():650708. PubMed ID: 33927721
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of JAK-STAT Signaling by Baricitinib Reduces Interferon-γ-Induced CXCL10 Production in Human Salivary Gland Ductal Cells.
Aota K; Yamanoi T; Kani K; Ono S; Momota Y; Azuma M
Inflammation; 2021 Feb; 44(1):206-216. PubMed ID: 32772240
[TBL] [Abstract][Full Text] [Related]
8. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells protect from hypoxia-induced alveolar epithelial-mesenchymal transition.
Uzunhan Y; Bernard O; Marchant D; Dard N; Vanneaux V; Larghero J; Gille T; Clerici C; Valeyre D; Nunes H; Boncoeur E; Planès C
Am J Physiol Lung Cell Mol Physiol; 2016 Mar; 310(5):L439-51. PubMed ID: 26702148
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6/JAK2/STAT3 signaling.
Lu J; Dong Q; Zhang S; Feng Y; Yang J; Zhao L
Cancer Sci; 2023 Aug; 114(8):3287-3300. PubMed ID: 37272257
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells.
Yang T; Chen M; Sun T
Cell Physiol Biochem; 2013; 31(6):863-74. PubMed ID: 23817018
[TBL] [Abstract][Full Text] [Related]
12. Baricitinib ameliorates inflammatory and neuropathic pain in collagen antibody-induced arthritis mice by modulating the IL-6/JAK/STAT3 pathway and CSF-1 expression in dorsal root ganglion neurons.
Makabe K; Okada H; Tachibana N; Ishikura H; Ito N; Tanaka M; Chijimatsu R; Terashima A; Yano F; Asaka M; Yanagihara D; Taketomi S; Matsumoto T; Tanaka S; Omata Y; Saito T
Arthritis Res Ther; 2024 Jun; 26(1):121. PubMed ID: 38879555
[TBL] [Abstract][Full Text] [Related]
13. Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms.
Montero P; Milara J; Roger I; Cortijo J
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207510
[TBL] [Abstract][Full Text] [Related]
14. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer.
Kachroo P; Lee MH; Zhang L; Baratelli F; Lee G; Srivastava MK; Wang G; Walser TC; Krysan K; Sharma S; Dubinett SM; Lee JM
J Exp Clin Cancer Res; 2013 Nov; 32(1):97. PubMed ID: 24274066
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z
Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381
[TBL] [Abstract][Full Text] [Related]
16. IL-23 amplifies the epithelial-mesenchymal transition of mechanically conditioned alveolar epithelial cells in rheumatoid arthritis-associated interstitial lung disease through mTOR/S6 signaling.
Zhang C; Wang S; Lau J; Roden AC; Matteson EL; Sun J; Luo F; Tschumperlin DJ; Vassallo R
Am J Physiol Lung Cell Mol Physiol; 2021 Dec; 321(6):L1006-L1022. PubMed ID: 34585990
[TBL] [Abstract][Full Text] [Related]
17. Effect of Liuweibuqi Capsules in Pulmonary Alveolar Epithelial Cells and COPD Through JAK/STAT Pathway.
Wang C; Ding H; Tang X; Li Z; Gan L
Cell Physiol Biochem; 2017; 43(2):743-756. PubMed ID: 28950251
[TBL] [Abstract][Full Text] [Related]
18. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway.
Yadav A; Kumar B; Datta J; Teknos TN; Kumar P
Mol Cancer Res; 2011 Dec; 9(12):1658-67. PubMed ID: 21976712
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen sulfide attenuates paraquat-induced epithelial-mesenchymal transition of human alveolar epithelial cells through regulating transforming growth factor-β1/Smad2/3 signaling pathway.
Bai YW; Ye MJ; Yang DL; Yu MP; Zhou CF; Shen T
J Appl Toxicol; 2019 Mar; 39(3):432-440. PubMed ID: 30265375
[TBL] [Abstract][Full Text] [Related]
20. IRF1 Mediates Growth Arrest and the Induction of a Secretory Phenotype in Alveolar Epithelial Cells in Response to Inflammatory Cytokines IFNγ/TNFα.
Recchia Luciani G; Barilli A; Visigalli R; Sala R; Dall'Asta V; Rotoli BM
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]